v3.26.1
PROPERTY, PLANT AND EQUIPMENT
 12 Months Ended
Dec. 31, 2025
Disclosure of detailed information about property, plant and equipment [abstract]  
PROPERTY, PLANT AND EQUIPMENT

7 PROPERTY, PLANT AND EQUIPMENT

 

   Building   Freehold land   Laboratory equipment   Motor vehicle   Furniture, fittings and equipment   Renovation   Right-of-use assets   Total 
   S$   S$   S$   S$   S$   S$   S$   S$ 
Cost:                                        
At January 1, 2024   1,060,463    372,206    1,209,171    47,061    283,143    457,403    -    3,429,447 
Addition   899,110    193,673    123,340    

-

    100,446    83,656    34,740    1,434,965 
Currency realignment   33,872    22,162    59,870    2,802    14,352    22,452    -    155,510 
At December 31, 2024   1,993,445    588,041    1,392,381    49,863    397,941    563,511    34,740    5,019,922 
Addition   -    -    571,190    

-

    47,233    19,427    54,255    692,105 
Written off   -    -    (3,859)   

-

    

-

    

-

    

-

    (3,859)
Currency realignment   60,214    23,575    66,098    1,999    15,680    20,017    3,199    190,782 
At December 31, 2025   2,053,659    611,616    2,025,810    51,862    460,854    602,955    92,194    5,898,950 
                                         
Accumulated depreciation:                                        
At January 1, 2024   113,649    -    801,368    45,492    234,031    170,154    -    1,364,694 
Addition   52,004    -    176,228    1,604    37,719    51,116    3,493    322,164 
Currency realignment   3,577    -    49,025    2,767    13,753    10,770    126    80,018 
At December 31, 2024   169,230    -    1,026,621    49,863    285,503    232,040    3,619    1,766,876 
Addition   69,282         187,486    -    39,711    58,587    15,976    371,042 
Written off   -    -    (701)   

-

    

-

    

-

    

-

    (701)
Currency realignment   4,219    

-

    41,859    1,999    11,341    10,046    677    70,141 
At December 31, 2025   242,731    -    1,255,265    51,862    336,555    300,673    20,272    2,207,358 
                                         
Carrying amount:                                        
At December 31, 2024   1,824,215    588,041    365,760    -    112,438    331,471    31,121    3,253,046 
                                         
At December 31, 2025   1,810,928    611,616    770,545    -    124,299    302,282    71,922    3,691,592 

 

 

CYTOMED THERAPEUTICS LIMITED AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Years ended December 31, 2023, 2024 and 2025

 

Motor vehicle is acquired under finance leasing arrangement which was fully paid in the year.

 

The right-of-use assets represent leases of an office premise and a laboratory. The lease of office premise is for 4 years from August 1, 2024 and the lease of laboratory is for 5 years from May 1, 2025. Details of the lease liabilities are disclosed in Note 13.

 

As of December 31, 2025, the Company capitalized right-of-use assets with an aggregate non-cash cost of S$54,255 (2024: S$34,740). As a result, the cash outflow on acquisition of property, plant and equipment amounting to S$637,850 (2024: 1,400,225) as disclosed in the consolidated statements of cash flows.

 

As of December 31, 2025, bank borrowing is secured by the freehold land and building of the Group with carrying amount of S$964,845 (2024: S$937,700).

 

Depreciation expense included in the consolidated statements of profit or loss and other comprehensive loss is analyzed as follows:

 

   2024   2025 
   S$   S$ 
         
Depreciation of property, plant and equipment (per above)   322,164    371,042 
Less: Accounted under          
“Research expenses” (Note 21)   (212,322)   (174,146)
Total   109,842    196,896